{
    "clinical_study": {
        "@rank": "70495", 
        "arm_group": [
            {
                "arm_group_label": "Training", 
                "arm_group_type": "Experimental", 
                "description": "Aerobic"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Not exercise"
            }
        ], 
        "brief_summary": {
            "textblock": "Aerobic physical activity attenuates systemic inflammatory activity in individuals with\n      cardiovascular risk."
        }, 
        "brief_title": "Anti-inflammatory Effect of Aerobic Exercise in Individual With Increased Cardiovascular Risk", 
        "completion_date": {
            "#text": "April 2008", 
            "@type": "Actual"
        }, 
        "condition": "Inflammation", 
        "condition_browse": {
            "mesh_term": "Inflammation"
        }, 
        "detailed_description": {
            "textblock": "Background: Observational studies suggest that exercise has anti-inflammatory effect,\n      however this idea has not been definitively confirmed by randomized clinical trials.\n\n      Objective: To test the hypothesis that aerobic exercise attenuates systemic inflammatory\n      activity in individuals with cardiovascular risk.\n\n      Methods: Randomized controlled trial, which included 68 sedentary individuals, with at least\n      two risk factors for coronary heart disease or established cardiovascular disease. The\n      volunteers were randomized to 3 months of supervised aerobic training or just advice when\n      healthy lifestyles. C-reactive protein (CRP) was measured by the method of high sensitivity\n      before and after 3 months of intervention."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - Individuals with are between 40 to 70 years, no regular exercise, and at least two risk\n        factor for cardiovascular disease (diabetes, hypertension, dyslipidemia, smoking) or\n        documented cardiovascular disease.\n\n        Exclusion Criteria:\n\n        - Incapacity to exercise."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "68", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01903941", 
            "org_study_id": "CRPExercise"
        }, 
        "intervention": [
            {
                "arm_group_label": "Training", 
                "intervention_name": "Aerobic Exercise", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Control", 
                "intervention_name": "Only Counseling", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Anti-Inflammatory Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "exercise", 
        "lastchanged_date": "July 17, 2013", 
        "number_of_arms": "2", 
        "official_title": "Anti-inflammatory Effect of Aerobic Exercise in Individual With Increased Cardiovascular Risk", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "C-reactive protein", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01903941"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Escola Bahiana de Medicina e Saude Publica", 
            "investigator_full_name": "Luis  CL Correia", 
            "investigator_title": "Associate Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Escola Bahiana de Medicina e Saude Publica", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Escola Bahiana de Medicina e Saude Publica", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2006", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}